Compounds > cyclopentenyluracil
Page last updated: 2024-09-03

cyclopentenyluracil and uracil

cyclopentenyluracil has been researched along with uracil in 5 studies

*Uracil: One of four nucleotide bases in the nucleic acid RNA. [MeSH]

*Uracil: One of four nucleotide bases in the nucleic acid RNA. [MeSH]

Compound Research Comparison

Studies
(cyclopentenyluracil)		Trials
(cyclopentenyluracil)		Recent Studies (post-2010)
(cyclopentenyluracil)		Studies
(uracil)		Trials
(uracil)		Recent Studies (post-2010) (uracil)
70111,3007152,532

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamson, PC; Balis, FM; Blaney, SM; Cole, DE; Grem, J; Poplack, DG1
De Clercq, E; Marquez, VE; Murase, J1
August, EM; Cysyk, RL; Malinowski, N; Marquez, V; Moyer, JD; Zaharevitz, D1
Guchelaar, HJ; Kulik, W; Leen, R; Schimmel, K; van Kuilenburg, A; van Lenthe, H; Verschuur, A1
Darout, E; Fields, GB; Hodder, P; Lauer, J; Liu, Q; Minond, D; Roth, J; Roush, WR1

Other Studies

5 other study(ies) available for cyclopentenyluracil and uracil

ArticleYear
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine.
    Cancer research, 1992, Jun-15, Volume: 52, Issue:12

    Topics: Cell Survival; Cytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia; Tumor Cells, Cultured; Uracil

1992
Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.
    Biochemical pharmacology, 1991, Jun-15, Volume: 41, Issue:12

    Topics: Adenosine; Amides; Antiviral Agents; Azauridine; Carbon-Nitrogen Ligases; Cell Division; Cytarabine; Cytidine; Deoxycytidine; Drug Synergism; Fluorouracil; HeLa Cells; Humans; Ligases; Nucleosides; Pyrazoles; Ribavirin; Ribonucleosides; Ribose; Thymidine; Tumor Cells, Cultured; Uracil; Virus Replication; Viruses

1991
Cyclopentenyl uracil: an effective inhibitor of uridine salvage in vivo.
    Biochemical pharmacology, 1995, Jan-18, Volume: 49, Issue:2

    Topics: Animals; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pyrimidine Nucleotides; Uracil; Uracil Nucleotides; Uridine; Uridine Kinase

1995
Quantitative analysis of the experimental cytotoxic drug cyclopentenyl cytosine and its metabolite in plasma with HPLC tandem mass spectrometry.
    Biomedical chromatography : BMC, 2008, Volume: 22, Issue:12

    Topics: Chromatography, High Pressure Liquid; Cytidine; Humans; Molecular Structure; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Uracil

2008
Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.
    Bioorganic & medicinal chemistry letters, 2011, Dec-01, Volume: 21, Issue:23

    Topics: Binding Sites; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Matrix Metalloproteinase 13; Matrix Metalloproteinase Inhibitors; Molecular Structure; Structure-Activity Relationship; Substrate Specificity; Uracil

2011